Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors

Abstract

Matrilysin is a matrix metalloproteinase expressed in the tumor cells of greater than 80% of intestinal adenomas. The majority of these intestinal tumors are associated with the accumulation of β-catenin, a component of the cadherin adhesion complex and, through its association with the T Cell Factor (Tcf) DNA binding proteins, a regulator in the Wnt signal transduction pathway. In murine intestinal tumors, matrilysin transcripts show striking overlap with the accumulation of β-catenin protein. The matrilysin promoter is upregulated as much as 12-fold by β-catenin in colon tumor cell lines in a manner inversely proportional to the endogenous levels of β-catenin/Tcf complex and is dependent upon a single optimal Tcf-4 recognition site. Coexpression of the E-cadherin cytoplasmic domain blocked this induction and reduced basal promoter activity in every colon cancer cell line tested. Inactivation of the Tcf binding site increased promoter activity and overexpression of the Tcf factor, LEF-1, significantly downregulated matrilysin promoter activity, suggesting that β-catenin transactivates the matrilysin promoter by virtue of its ability to abrogate Tcf-mediated repression. Because genetic ablation of matrilysin decreases tumor formation in multiple intestinal neoplasia (Min) mice, we propose that regulation of matrilysin production by β-catenin accumulation is a contributing factor to intestinal tumorigenesis.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Aberle H, Schwartz H and Kemler R. . 1996 J. Cell Biochem. 61: 514–523.

  • Arribas J, Coodly L, Vollmer P, Kishimoto TK, Rose-John S and Massague J. . 1996 J. Biol. Chem. 271: 11376–11382.

  • Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA and Struhl K (eds). . 1993 In: Current Protocols in Molecular Biology. John Wiley & Sons: New York.

    Google Scholar 

  • Behrens J, Von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R and Birchmeier W. . 1996 Nature 382: 638–642.

  • Borchers AH, Sanders LA and Bowden GT. . 1997 Cancer Res. Clin. Oncol. 123: 13–20.

  • Brannon M, Gomperts M, Sumoy L, Moon RT and Kimelman D. . 1997 Genes Dev. 11: 2359–2370.

  • Cavallo R, Cox R, Moline M, Roose J, Polevoy G, Clevers H, Peifer M and Bejsovec A. . 1998 Nature 395: 604–608.

  • Chambers AF and Matrisian LM. . 1997 J. Natl. Cancer Inst. 89: 1260–1270.

  • Crawford HC and Matrisian LM. . 1996 Enz. Prot. 49: 20–37.

  • Damsky CH, Moursi A, Zhou Y, Fisher SJ and Globus RK. . 199 Kidney Intl. 51: 1427–1433.

  • Dempsey PJ, Meise KS, Yoshitake Y, Nishikawa K and Coffey RJ. . 1997 J. Cell. Biol. 138: 747–758.

  • Fagotto F, Funayama N, Gluck U and Gumbiner BM. . 1996 J. Cell. Biol. 132: 1105–1114.

  • Gaire M, Magbanua Z, McDonnell S, McNeil L, Lovett DH and Matrisian LM. . 1994 J. Biol. Chem. 269: 2032–2040.

  • Gearing AJH, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL, Leber TM, Mangan M, Miller K, Nayee P, Owen K, Patel S, Thomas W, Wells G, Wood LM and Woolley K. . 1994 Nature 370: 555–557.

  • Giese K, Cox J and Grosschedl R. . 1992 Cell 69: 185–195.

  • Groden J, Thilveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson M, Sargeant L, Krapcho K, Wolf E, Burt R, Hughes JP, Warrington J, McPherson J, Wasmuth J, Le Paslier, Abderrahim H, Cohen D, Leppert M and White R. . 1991 Cell 66: 589–600.

  • Groden J, Joslyn G, Samowitz W, Jones D, Bhattacharyya N, Spirio L, Thilveris A, Robertson M, Egan S and Meuth M. . 1995 Cancer Res. 55: 1531–1539.

  • He T, Sparks A, Rago C, Hermeking H, Zawel L, Dacosta L, Morin P, Vogelstein B and Kinzler K. . 1998 Science 281: 1509–1512.

  • Herren B, Levkau B, Raines EW and Ross R. . 1998 Mol. Biol. Cell 9: 1589–1601.

  • Ilyas M, Tomlinson IP, Rowan A, Pignatelli M and Bodmer WF. . 1997 Proc. Natl. Acad. Sci. USA 9: 10330–10334.

  • Jou TS, Stewart DB, Stappert J, Nelson WJ and Marrs JA. . 1995 Proc. Natl. Acad. Sci. USA 92: 5067–5071.

  • Kayagaki N, Kawasaki A, Ebata T, Ohmoto H, Ikeda S, Inoue S, Yoshino K, Okumura K and Yagita H. . 1995 J. Exp. Med. 182: 1777–1783.

  • Kinzler KW and Vogelstein B. . 1996 Cell 87: 159–170.

  • Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B and Clevers H. . 1997 Science 275: 1784–1787.

  • Levanon D, Goldstein R, Bernstein Y, Tang H, Goldenberg D, Stifani S, Paroush Z and Groner Y. . 1998 Proc. Natl. Acad. Sci. USA 95: 11590–1155.

  • Levi E, Fridman R, Miao HQ, Ma YS, Yayon A and Vlodavsky I. . 1996 Proc. Natl. Acad. Sci. USA 93: 7069–7074.

  • Lochter A, Galosy S, Muschler J, Freedman N, Werb Z and Bissell MJ. . 1997 J. Cell. Biol. 139: 1861–1872.

  • Love JJ, Li X, Case DA, Giese K, Grosschedl R and Wright PE. . 1995 Nature 376: 791–795.

  • McKendry R, Hsu SC, Harland RM and Grosschedl R. . 1997 Dev. Biol. 192: 420–431.

  • Morin PJ, Vogelstein B and Kinzler KW. . 1996 Proc. Natl. Acad. Sci. USA 93: 7950–7954.

  • Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B and Kinzler KW. . 1997 Science 275: 1787–1790.

  • Mullberg J, Durie FH, Otten-Evans C, Alderson MR, Rose-John S, Cosman D, Black RA and Mohler KM. . 1995 J. Immunol. 155: 5198–5205.

  • Munemitsu S, Albert I, Souza B, Rubinfeld B and Polakis P. . 1995 Proc. Natl. Acad. Sci. USA 92: 3046–3050.

  • Munemitsu S, Albert I, Rubinfeld B and Polakis P. . 1996 Mol. Cell. Biol. 16: 4088–4094.

  • Newell KJ, Witty JP, Rodgers WH and Matrisian LM. . 1994 Mol. Carcinogenesis 10: 199–206.

  • Pilcher BK, Dumin JA, Sudbeck BD, Krane SM, Welgus HG and Parks WC. . 1997 J. Cell. Biol. 137: 1445–1457.

  • Roose J, Molenaar M, Peterson J, Hurenkamp J, Brantjes H, Moerer P, van de Wetering M, Destree O and Clevers H. . 1998 Nature 395: 608–612.

  • Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S and Polakis P. . 1996 Science 272: 1023–1026.

  • Sparks AB, Morin PJ, Vogelstein B and Kinzler KW. . 1998 Cancer Res. 58: 1130–1134.

  • Stewart DB and Nelson WJ. . 1997 J. Biol. Chem. 47: 29652–2966.

  • Suzuki M, Raab G, Moses MA, Fernandez CA and Klagsbrun M. . 1997 J. Biol. Chem. 272: 31730–31737.

  • Takeuchi N, Ichikawa Y, Ishikawa T, Momiyama N, Hasegawa S and Nagashima Y. . 1998 Mol. Carcinogenesis 19: 225–229.

  • Von Bredow DC, Nagle RB, Bowden GT and Cress AE. . 1997 Exp. Cell Res. 236: 341–345.

  • Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C and Bissell MJ. . 1997 J. Cell. Biol. 137: 231–245.

  • Wilson CL, Heppner KJ, Rudolph LA and Matrisian LM. . 1995 Mol. Biol. Cell 6: 851–869.

  • Wilson CL, Heppner KJ, Labosky PA, Hogan BLM and Matrisian LM. . 1997 Proc. Natl. Acad. Sci. USA 94: 1402–1407.

  • Wilson CL and Matrisian LM. . 1998 In: Matrix Metalloproteinases. Parks WC and Mecham RP (eds).. Academic Press: San Diego pp. 149–184.

    Book  Google Scholar 

  • Witty JP, McDonnell S, Newell K, Cannon P, Navre M, Tressler R and Matrisian LM. . 1994 Cancer Res. 54: 4805–4812.

  • Zhou P, Byrne C, Jacobs J and Fuchs E. . 1995 Genes Dev. 9: 700–713.

Download references

Acknowledgements

We would like to thank Dr C Wilson for aid in promoter cloning and construction; and Dr E Fuchs for the LEF-1 expression construct. This work was supported by grants and fellowships from the NIH to LMM (R01 CA60867) and HCC (F32 CA67429) and by the Vanderbilt Cancer Center Support Grant (P30 CA68485).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Crawford, H., Fingleton, B., Rudolph-Owen, L. et al. The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors. Oncogene 18, 2883–2891 (1999). https://doi.org/10.1038/sj.onc.1202627

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202627

Keywords

This article is cited by

Search

Quick links